Popular in Course
verified elite notetaker
Popular in none
This 3 page Document was uploaded by an elite notetaker on Tuesday December 22, 2015. The Document belongs to a course at a university taught by a professor in Fall. Since its upload, it has received 7 views.
Reviews for Vice-President-Marketing-Business-Development-in-Raleigh-Durham-NC-Resume-Thomas-Compton
Report this Material
What is Karma?
Karma is the currency of StudySoup.
You can buy or earn more Karma at anytime and redeem it for class notes, study guides, flashcards, and more!
Date Created: 12/22/15
THOMAS V. COMPTON Home: (858) 481-4001 San Diego, CA 92130 email@example.com Mobil : (858) 775-2888 DYNAMIC BIOPHARMACEUTICAL EXECUTIVE Proven leadership and management experience in the successful operation of established pharmaceutical and startup biotech companies: commercial operations, sales and marketing, new product launches, business development and product development. Expertise in Dermatology, Aesthetics, Medical Diagnostics, Pain Management, Respiratory Medicine, Rheumatology, Ophthalmics, Anti Infectives and Anesthetics. PROFESSIONAL EXPERIENCE PROVERI INC. 2008-2011 Vice President, Business Development Multiple responsibilities with an early stage start-up biotech company that is developing diagnostics, prognostics and theranostics for prostate cancer. Led the development and multiple revisions to the company business plan, investor presentation and also interfaced with many potential investors to schedule presentations. Established key physician contacts in both Urology and Pathology for advisors, consultants and possible members of the Scientific Advisory Board. Led multiple partnering meetings at both BIO and Biopartnering North American annual meeting. BIO-PHARMACEUTICAL STRATEGIC BUSINESS CONSULTING & 2003-2008 ORTHONEUTROGENA (A Johnson & Johnson Company) Director, Aesthetics Marketing Consulting services provided in strategic/tactical planning, marketing, market research, forecasting, clinical development planning for commercialization, assessment of new business opportunities and KOL development. Opened offices for a small venture funded proteomic tools company in California. Served as Vice President & General Manager of West Coast Operations. As Director of Aesthetics Marketing, led the OrthoNeutrogena team ((subsidiary of Johnson & Johnson) and its corporate partner (ZARS, Inc.) in the execution of all deliverables, completion of the required clinical trials and resubmission of an NDA for a topical anesthetic peel for usage with aesthetic procedures. Corporate savings of more than $30M realized from decision not to launch product. LIGAND PHARMACEUTICALS INC. San Diego, CA 2001-2003 Senior Director, Supportive Care Marketing Joined Ligand to develop the Supportive Care/Pain Marketing Group and direct the launch of AVINZA into the $2.3B sustained-release opioid market. Worked with partner company (Élan) to develop a plan and timeline for resubmission of the NDA. Drove the assignment of tasks and responsibilities of the Ligand Project Development Team that included multidisciplinary departments and partner company. Executed Ligand’s most successful product launch and launch meeting, sales training and certification examination without a product manager ($150M in 4 yrs) THOMAS V. COMPTON P a g e | 2 SKINMEDICA, INC. Carlsbad, CA 2000-2001 Chief Executive Officer Negotiated a Licensing/Supply Agreement with Advanced Tissue Sciences, Inc. for NouriCel. Agreement was a milestone for SkinMedica and created a proprietary product for the folio to be used for the creation of an entire line of products containing epidermal growth factors. Conducted mini road shows and secured three sponsors from Tech Coast Angels and pitched company to private investors. Recruited and facilitated a prestigious Aesthetic Physician’s Advisory Board that became team of clinical investigators for clinical evaluation of NouriCel in skin rejuvenation. Decreased average monthly cash burn rate from $108K to an average of $75K. ICN PHARMACEUTICALS, INC, Costa Mesa, CA 1999-2000 Acting Division Manager/Vice President Sales and Marketing Joined ICN when U.S. Division was required to deliver additional revenues. Responsible for U.S. Pharmaceuticals and reported to the Group Vice President North America and Latin America. Led a staff of 92 with 16 direct reports, including Market Research, Regional Sales Managers and Product Managers. Total revenues for 1999 exceeded $122M with a 28% increase in profit from prior years. Launched Kinerase to professional cosmeceutical market (Dermatologists) with a consumer DTC campaign that drove patients to the physician, generating $12M in sales in seven months. Team Leader for product line extensions, life cycle planning for products in multiple therapeutic areas. Maximized corporate profits with a $2M reduction in expenses. DURA PHARMACEUTICALS, San Diego, CA 1994-1999 Senior Director, Marketing Worked with Business Development to solidify the company’s paramount product acquisition, Ceclor CD. Developed marketing plan, coordinated the national launch and representative training within a window of only 11 weeks, and DDMAC approved promotional materials were available at launch. The product gained 7.5% share in the Ceclor market in two months and a 25% market share within 14 months Managed partner relationship with Eli Lilly and directed promotional material review/approval with partner. Completed a detailed product life cycle plan for the Spiros System that included multiple therapies for inhalation. Initiated and managed a co-promotion with Bausch and Lomb Pharmaceuticals for Crolom contributing $1.5M additional profit to company’s bottom line. Revitalized line of older cough, cold, and allergy products with a 58% growth in revenues BAUSCH & LOMB PHARMACEUTICALS, INC., Tampa, FL 1991-1994 Director, Marketing Re-launched OptiPranolol resulting in sales growth from $0.8M to $3.8M in 1992, and $7.5M. Led and directed the project plan for R&D development of new generic products, product line extensions and in licensing opportunities. Chaired the team with VP R&D and drove the development and approval of first products. PURDUE PHARMA, Norwalk, CT 1986-1991 Director, Product Management/Ethical Product Coordinated and managed marketing programs for MS Contin (opioid analgesic), Uniphyl (bronchodilator), Trilisate (antiarthritic) and other prescription products. THOMAS V. COMPTON P a g e | 3 Contribution of prescription products grew from 21% to more than 50% Expanded sales of MS Contin 48% exceeding budget by $4.5M, tracking to $100M. BRISTOL LABORATORIES, Division of Bristol-Myers Co., Syracuse, NY 1985-1986 Significantly exceeded profit objective by $3M with aggressive bidding strategies for broad spectrum penicillins. Executed a computerized cephalosporin cost analysis program, which generated more than $2M additional sales for Cefadyl. ASTRA PHARMACEUTICAL PRODUCTS, INC., Westborough, MA 1975-1985 Held key positions with increasing scope and responsibilities including: Product Manager, Eastern Area Sales Manager, District Sales Manager, Hospital Specialist, and Pharmaceutical Sales Representative. EDUCATION MBA—Sacred Heart University, John Welch School of Business Administration Medical Marketing Program, UCLA Anderson School of Management BA—History (Special Business Administration Program), University of North Carolina PROFESSIONAL AFFILIATIONS - CONNECT Entrepreneur in Residence - American Society of Laser Medicine & Surgery Advisory Task Force (2005-2007) - Former Corporate Member: American Academy of Dermatology - Co-Chair-The Corporate Leadership Forum Sponsored by The Consultants’ Forum (05/09) - The Prostate Cancer Research Institute - BIO - Prostate Cancer Foundation -Instructor, Business, Advertising, Marketing and Finance at San Diego University for Integrative Studies
Are you sure you want to buy this material for
You're already Subscribed!
Looks like you've already subscribed to StudySoup, you won't need to purchase another subscription to get this material. To access this material simply click 'View Full Document'